IOBCF
Price
$13.35
Change
-$0.06 (-0.45%)
Updated
Jun 26 closing price
Capitalization
472.05M
VERO
Price
$2.57
Change
-$0.38 (-12.88%)
Updated
Jul 3 closing price
Capitalization
4.45M
Interact to see
Advertisement

IOBCF vs VERO

Header iconIOBCF vs VERO Comparison
Open Charts IOBCF vs VEROBanner chart's image
Ion Beam Applications S.A
Price$13.35
Change-$0.06 (-0.45%)
Volume$100
Capitalization472.05M
Venus Concept
Price$2.57
Change-$0.38 (-12.88%)
Volume$241.13K
Capitalization4.45M
IOBCF vs VERO Comparison Chart in %
Loading...
IOBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IOBCF vs. VERO commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOBCF is a Hold and VERO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (IOBCF: $13.35 vs. VERO: $2.57)
Brand notoriety: IOBCF and VERO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IOBCF: 29% vs. VERO: 13%
Market capitalization -- IOBCF: $472.05M vs. VERO: $4.45M
IOBCF [@Medical Specialties] is valued at $472.05M. VERO’s [@Medical Specialties] market capitalization is $4.45M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IOBCF’s FA Score shows that 1 FA rating(s) are green whileVERO’s FA Score has 0 green FA rating(s).

  • IOBCF’s FA Score: 1 green, 4 red.
  • VERO’s FA Score: 0 green, 5 red.
According to our system of comparison, both IOBCF and VERO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IOBCF’s TA Score shows that 3 TA indicator(s) are bullish while VERO’s TA Score has 5 bullish TA indicator(s).

  • IOBCF’s TA Score: 3 bullish, 3 bearish.
  • VERO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VERO is a better buy in the short-term than IOBCF.

Price Growth

IOBCF (@Medical Specialties) experienced а 0.00% price change this week, while VERO (@Medical Specialties) price change was +16.82% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

VERO is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IOBCF($472M) has a higher market cap than VERO($4.45M). IOBCF YTD gains are higher at: -3.646 vs. VERO (-37.945). IOBCF has higher annual earnings (EBITDA): 22M vs. VERO (-26.29M). IOBCF has more cash in the bank: 195M vs. VERO (4.93M). IOBCF has less debt than VERO: IOBCF (64.7M) vs VERO (83.9M). IOBCF has higher revenues than VERO: IOBCF (336M) vs VERO (82.5M).
IOBCFVEROIOBCF / VERO
Capitalization472M4.45M10,609%
EBITDA22M-26.29M-84%
Gain YTD-3.646-37.94510%
P/E Ratio68.03N/A-
Revenue336M82.5M407%
Total Cash195M4.93M3,959%
Total Debt64.7M83.9M77%
FUNDAMENTALS RATINGS
IOBCF vs VERO: Fundamental Ratings
IOBCF
VERO
OUTLOOK RATING
1..100
9590
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
35
Fair valued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
74100
PRICE GROWTH RATING
1..100
5957
P/E GROWTH RATING
1..100
79100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IOBCF's Valuation (7) in the null industry is in the same range as VERO (35). This means that IOBCF’s stock grew similarly to VERO’s over the last 12 months.

IOBCF's Profit vs Risk Rating (74) in the null industry is in the same range as VERO (100). This means that IOBCF’s stock grew similarly to VERO’s over the last 12 months.

IOBCF's SMR Rating (74) in the null industry is in the same range as VERO (100). This means that IOBCF’s stock grew similarly to VERO’s over the last 12 months.

VERO's Price Growth Rating (57) in the null industry is in the same range as IOBCF (59). This means that VERO’s stock grew similarly to IOBCF’s over the last 12 months.

IOBCF's P/E Growth Rating (79) in the null industry is in the same range as VERO (100). This means that IOBCF’s stock grew similarly to VERO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IOBCFVERO
RSI
ODDS (%)
Bearish Trend 1 day ago
46%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
49%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
62%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
60%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
52%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
IOBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSII5.340.17
+3.29%
SS Innovations International Inc
RSI15.040.12
+0.80%
Rush Street Interactive
ALLY41.210.31
+0.76%
Ally Financial
ASRT0.65-0.02
-3.23%
Assertio Holdings
PBM5.20-0.44
-7.88%
Psyence Biomedical Ltd

IOBCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOBCF has been loosely correlated with ANSLY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IOBCF jumps, then ANSLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOBCF
1D Price
Change %
IOBCF100%
N/A
ANSLY - IOBCF
43%
Loosely correlated
N/A
BRSYF - IOBCF
39%
Loosely correlated
N/A
PXMBF - IOBCF
30%
Poorly correlated
N/A
FSPKF - IOBCF
21%
Poorly correlated
N/A
VERO - IOBCF
20%
Poorly correlated
-12.88%
More

VERO and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERO has been loosely correlated with CRL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if VERO jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERO
1D Price
Change %
VERO100%
-12.88%
CRL - VERO
35%
Loosely correlated
-0.23%
RVTY - VERO
34%
Loosely correlated
+0.41%
ISRG - VERO
34%
Loosely correlated
+0.72%
ATR - VERO
34%
Loosely correlated
+0.45%
ANSLY - VERO
33%
Loosely correlated
N/A
More